Should I discontinue statin (HMG-CoA reductase inhibitor) therapy now that my Low-Density Lipoprotein (LDL) cholesterol level is 55 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Low LDL Cholesterol (55 mg/dL)

You should continue your statin therapy despite achieving an LDL cholesterol level of 55 mg/dL, as this level is actually at the target goal for high-risk patients with established cardiovascular disease. 1

Understanding LDL Targets in Cardiovascular Disease

Current guidelines from major cardiovascular societies recommend specific LDL cholesterol targets based on cardiovascular risk:

  • For patients with established atherosclerotic cardiovascular disease (ASCVD): LDL-C target of <55 mg/dL (1.4 mmol/L) and a ≥50% reduction from baseline 1
  • For patients who experience a second vascular event within 2 years while on statin therapy: even lower LDL-C goal of <40 mg/dL (1.0 mmol/L) 1

Your current LDL level of 55 mg/dL is precisely at the target recommended for high-risk patients, indicating successful lipid management.

Benefits of Continuing Statin Therapy

Continuing statin therapy despite achieving target LDL levels provides several important benefits:

  • Sustained cardiovascular protection: The 2024 International Lipid Expert Panel (ILEP) position paper emphasizes maintaining LDL-C below 55 mg/dL to reduce the risk of recurrent cardiovascular events 1
  • Plaque stabilization: Ongoing statin therapy helps stabilize existing atherosclerotic plaques
  • Anti-inflammatory effects: Statins provide benefits beyond LDL lowering through their pleiotropic effects
  • Mortality reduction: Meta-analyses demonstrate a 9% reduction in all-cause mortality and 13% reduction in vascular mortality for each 39 mg/dL reduction in LDL cholesterol 1

Monitoring Recommendations

While continuing statin therapy, follow these monitoring guidelines:

  • Check lipid levels every 3-6 months initially, then annually once stable at goal 2
  • Monitor for muscle symptoms and check CK if symptoms develop 2
  • Consider annual liver function tests while on statin therapy 2

Special Considerations

If you experience side effects from your current statin regimen, consider these options rather than discontinuation:

  1. Dose adjustment: Reducing the dose while maintaining therapy may help manage side effects
  2. Statin switching: Changing to a different statin (particularly pitavastatin for those with metabolic disorders) 1
  3. Alternative dosing schedule: Using an intermittent dosing regimen (e.g., every other day) for those with mild statin intolerance

When to Consider Statin Discontinuation

Statin discontinuation should only be considered in specific circumstances:

  • Severe, persistent side effects despite multiple statin trials and dose adjustments
  • Development of severe liver dysfunction attributed to statin therapy
  • Pregnancy planning, pregnancy, or breastfeeding 1
  • Terminal illness with limited life expectancy

Conclusion

Your LDL cholesterol of 55 mg/dL indicates successful lipid management and is at the target recommended by current guidelines. Continuing statin therapy is strongly recommended to maintain this cardiovascular protection and prevent future events.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperlipidemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.